TSH Biopharm Corporation Limited (8432.TWO)

TWD 60.7

(-2.72%)

Total Liabilities Summary of TSH Biopharm Corporation Limited

  • TSH Biopharm Corporation Limited's latest annual total liabilities in 2023 was 133.62 Million TWD , down -39.93% from previous year.
  • TSH Biopharm Corporation Limited's latest quarterly total liabilities in 2024 Q2 was 224.2 Million TWD , up 93.22% from previous quarter.
  • TSH Biopharm Corporation Limited reported annual total liabilities of 222.45 Million TWD in 2022, up 159.27% from previous year.
  • TSH Biopharm Corporation Limited reported annual total liabilities of 85.8 Million TWD in 2021, down -16.73% from previous year.
  • TSH Biopharm Corporation Limited reported quarterly total liabilities of 224.2 Million TWD for 2024 Q2, up 93.22% from previous quarter.
  • TSH Biopharm Corporation Limited reported quarterly total liabilities of 133.62 Million TWD for 2023 Q4, up 82.67% from previous quarter.

Annual Total Liabilities Chart of TSH Biopharm Corporation Limited (2023 - 2019)

Historical Annual Total Liabilities of TSH Biopharm Corporation Limited (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 133.62 Million TWD -39.93%
2022 222.45 Million TWD 159.27%
2021 85.8 Million TWD -16.73%
2020 103.03 Million TWD -25.76%
2019 138.79 Million TWD 0.0%

Peer Total Liabilities Comparison of TSH Biopharm Corporation Limited

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 85.318%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD 52.705%
Easywell Biomedicals, Inc. 589.98 Million TWD 77.351%
TTY Biopharm Company Limited 3.36 Billion TWD 96.033%
Synmosa Biopharma Corporation 3.62 Billion TWD 96.316%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 97.99%
Center Laboratories, Inc. 6.78 Billion TWD 98.031%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD 17.029%
Orient Pharma Co., Ltd. 892.18 Million TWD 85.023%
InnoPharmax Inc. 48.64 Million TWD -174.674%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD 58.371%
Excelsior Biopharma Inc. 472.87 Million TWD 71.742%
DV Biomed Co., Ltd. 765.87 Million TWD 82.552%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 78.34%
Handa Pharmaceuticals, Inc. 280.88 Million TWD 52.426%
UniPharma Co., Ltd. 37.4 Million TWD -257.279%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 86.839%
Alar Pharmaceuticals Inc. 76.08 Million TWD -75.618%
Winston Medical Supply Co., Ltd. 373.87 Million TWD 64.259%
Mercury Biopharmaceutical Corporation 49.72 Million TWD -168.752%
Bioray Biotech Co., Ltd 108.75 Million TWD -22.872%